Moreover, in 144 RCC patients from Peking University First Hospital, immunostaining results confirmed that ccRCC patients with low CLDN7 protein expression levels experienced recurrent or metastatic tumors earlier after surgery, compared to those with higher expression levels (Fig. 1g). Here, CLDN7 is linked to nonpapillary renal cell carcinoma.